Andrew NE, Kilkenny MF, Naylor R, Purvis T, Cadilhac DA The relationship between caregiver impacts and the unmet needs of survivors of stroke. Patient Prefer Adherence. 2015 Jul 27;9:1065-73. doi: 10.2147/PPA.S85147. eCollection 2015.
Bachner YG Preliminary assessment of the psychometric properties of the abridged Arabic version of the Zarit Burden Interview among caregivers of cancer patients. Eur J Oncol Nurs. 2013 Oct;17(5):657-60. doi: 10.1016/j.ejon.2013.06.005. Epub 2013 Jul 15.
Caro CC, Costa JD, Da Cruz DMC Burden and Quality of Life of Family Caregivers of Stroke Patients. Occup Ther Health Care. 2018 Apr;32(2):154-171. doi: 10.1080/07380577.2018.1449046. Epub 2018 Mar 26.
Eames S, Hoffmann T, Worrall L, Read S, Wong A Randomised controlled trial of an education and support package for stroke patients and their carers. BMJ Open. 2013 May 8;3(5). pii: e002538. doi: 10.1136/bmjopen-2012-002538.
Gbiri CA, Olawale OA, Isaac SO Stroke management: Informal caregivers' burdens and strians of caring for stroke survivors. Ann Phys Rehabil Med. 2015 Apr;58(2):98-103. doi: 10.1016/j.rehab.2014.09.017. Epub 2015 Jan 7.
Hekmatpou D, Mohammad Baghban E, Mardanian Dehkordi L The effect of patient care education on burden of care and the quality of life of caregivers of stroke patients. J Multidiscip Healthc. 2019 Mar 20;12:211-217. doi: 10.2147/JMDH.S196903. eCollection 2019. Erratum in: J Multidiscip Healthc. 2019 Nov 05;12:881.
Jeong YG, Jeong YJ, Kim WC, Kim JS The mediating effect of caregiver burden on the caregivers' quality of life. J Phys Ther Sci. 2015 May;27(5):1543-7. doi: 10.1589/jpts.27.1543. Epub 2015 May 26.
Karagiozi, K , Papastavrou, E., Giaglis, G., Pattakou, V., Kosta-Tsolaki, M., & Papaliagkas, V. (2014). Combined Intervention for Caregivers of Patients with Dementia: A Randomized Controlled Trial. International Journal of Academic Research in Psychology, 1(2), 77-95. https://doi.org/10.6007/IJARP/v1-i2/1203
Lutz, B J., & Camicia, M. (2016). Supporting the needs of stroke caregivers across the care continuum. Journal of Clinical Outcomes Management, 23(12), 557-566.
Shata ZN, Amin MR, El-Kady HM, Abu-Nazel MW Efficacy of a multi-component psychosocial intervention program for caregivers of persons living with neurocognitive disorders, Alexandria, Egypt: A randomized controlled trial. Avicenna J Med. 2017 Apr-Jun;7(2):54-63. doi: 10.4103/2231-0770.203610.
Tsai PC, Yip PK, Tai JJ, Lou MF Needs of family caregivers of stroke patients: a longitudinal study of caregivers' perspectives. Patient Prefer Adherence. 2015 Mar 18;9:449-57. doi: 10.2147/PPA.S77713. eCollection 2015.
Watanabe A, Fukuda M, Suzuki M, Kawaguchi T, Habata T, Akutsu T, Kanda T Factors decreasing caregiver burden to allow patients with cerebrovascular disease to continue in long-term home care. J Stroke Cerebrovasc Dis. 2015 Feb;24(2):424-30. doi: 10.1016/j.jstrokecerebrovasdis.2014.09.013. Epub 2014 Dec 12.
White, C L., Cantu, A. G., & Trevino, M. M. (2015). Interventions for caregivers of stroke survivors: An update of the evidence. Clinical Nursing Studies, 3(3), 87-95. https://doi.org/10.5430/cns.v3n3p87
Effect of a Tailored Multidimensional Intervention on the Care Burden Among Family Caregivers of Stroke Survivors
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
